Mangalam Drugs (MANGALAM)

STALWART

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹28.25
Market Cap₹46.03 Cr
P/E Ratio0
ROCE8.03%
ROE-20.76%
Dividend Yield0%
Profit Growth-798.57%
Debt/Equity0.8
Sales Growth-34.07%
Promoter Holding35.64%
52-Week Range₹22.8 — ₹95
SectorPharmaceuticals & Biotechnology
Book Value₹87.8

Mangalam Drugs trades with ROCE of 8.03%, ROE of -20.76%, profit growth of -798.57%, debt-to-equity of 0.8.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer